4//SEC Filing
CODE KENNETH REAY 4
Accession 0001437749-20-020685
CIK 0000880242other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:58 PM ET
Size
15.1 KB
Accession
0001437749-20-020685
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
CODE KENNETH REAY
DirectorChief Technology Officer10% Owner
Transactions
- Award
Common stock
2020-09-30$0.15/sh+185,339$27,801→ 24,107,807 total
Footnotes (3)
- [F1]Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
- [F2]Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.
- [F3]The shares issued are unvested and subject to a Lock-Up Agreement dated as of the issuance date whereby shares vest only upon the earlier of (i) the sale of the Issuer of substantially all of its assets, (ii) the successful commercialization of Issuer's products or technologies as demonstrated by its receipt of at least $3,000,000 in cash, or the recognition of $3,000,000 in revenue, over a 12-month period from the sale of products and/or the license of technology; and (iii) the Company's breach of the employment agreement between the Company and Reporting Person and resulting in Reporting Person's termination.
Documents
Issuer
BIOLARGO, INC.
CIK 0000880242
Entity typeother
Related Parties
1- filerCIK 0001370684
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:58 PM ET
- Size
- 15.1 KB